Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

Shire Basingstoke

Shire receives FDA nod for self-infusion of Glassia

The company has also struck a deal with Pfizer to expand its GI portfolio

The death of deference

We are entering an age when authority matters less

- PMLiVE

Boyds expands regulatory affairs team

Céline Courtay-Cahen joins the pharma and biotech consultancy

Dr Alan Joslyn becomes president and CEO of Oragenics

He will also serve on the company’s board of directors

- PMLiVE

Boehringer Ingelheim launches ‘gamified’ COPD initiative

Programme aims to encourage and reward disease management

- PMLiVE

SMC approves Amgen orphan drug for use in NHS Scotland

Also accepts AbbVie's former orphan drug Duodopa, but rejects Sanofi's Jevtana

- PMLiVE

The value of early asset development and commercialisation

Linking the clinical benefit of a product to a real-world benefit that markets care about, insurers will pay for and that will improve patients’ lives is critical for pipeline assets...

UK flag

UK biotech beats fundraising records in 2015, says BIA

Record-breaking amount accounts for a third of all EU biotech venture finance last year

Sanofi reception

Sanofi launches community health project in China

Partners with local associations to improve chronic disease management

Roche Basel Switzerland

Roche’s Gazyvaro cleared for follicular lymphoma in Europe

Second indication anticipated to increase peak sales by up to $1bn

- PMLiVE

Celyad appoints Dr David Gilham as R&D vice president

He will resign from the company’s advisory board to fulfill his new role

- PMLiVE

Judith Moore joins Portland Health

She becomes an associate director at the agency

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links